XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.4
Common Stock, Stock Options and Warrants (Details) - USD ($)
 1 Months Ended 12 Months Ended
May 08, 2023
Sep. 13, 2022
Mar. 21, 2022
Nov. 02, 2021
Mar. 27, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Aug. 14, 2024
Aug. 08, 2024
Apr. 29, 2023
Common Stock, Stock Options and Warrants [Line Items]                      
Stock issued at direct offerings, shares 12,500,001 81,500 100,000 50,201 100,000            
Fair value of common stock issued (in Dollars)   $ 104,320 $ 178,000 $ 95,884 $ 102,000            
Warrants to purchase common shares 12,500,001                    
Share price per value (in Dollars per share) $ 1.2                    
Gross proceeds (in Dollars) $ 15,000,001                    
Exercise price (in Dollars per share) $ 1.5                    
Fair value of warrants (in Dollars) $ 11,000,000                    
Net proceed (in Dollars) 13,798,183                    
Options to purchase shares expired           198,333          
Common shares reserved           12,035,000          
Option to purchase share outstanding           300,000          
Shares available for future grants           11,735,000          
Contractual term           10 years          
Share issued price per share (in Dollars per share)           $ 0.98 $ 1.67        
Options vest over terms           10 years 10 years        
Stock-based compensation expense (in Dollars)           $ 6,616,705 $ 3,905,954        
Citius stock plans (in Dollars)           $ 4,840,874          
Weighted average period term           1 year 6 months 10 days          
Granted options to purchase           9,400,171 13,305,171        
Weighted average exercise price per share (in Dollars per share)           $ 1.26          
options to purchase were exercisable           6,558,507          
Term of options outstanding           7 years 4 months 28 days          
Private Placement [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Agent fee (in Dollars) 1,050,000                    
Agent expenses (in Dollars) 85,000                    
Legal fees (in Dollars) 50,868                    
Other offering expenses (in Dollars) $ 15,950                    
Warrant [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Issuance of warrant           50,923,819          
Weighted average period           2 years 8 months 19 days          
Deemed dividend (in Dollars)           $ 1,151,208          
Aggregate intrinsic value (in Dollars)           0          
Warrant [Member] | Private Placement [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Exercise price (in Dollars per share) $ 1.5                    
Fair value of warrants (in Dollars)           $ 771,000          
Issuance of warrant 875,000                    
Forecast [Member] | Warrant [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Purchase of warrant                 3,921,569 189,412  
Exercise price per share (in Dollars per share)                 $ 1.15 $ 1.59  
2014 Stock Incentive Plan [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Warrants to purchase common shares           4,829          
Common stock for issuance           866,667          
Shares outstanding           795,171          
Options to purchase shares expired           66,667          
2018 Omnibus Stock Incentive Plan [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Warrants to purchase common shares           116,667          
Common stock for issuance           2,000,000          
Shares outstanding           1,760,000          
Options to purchase shares expired           13,333          
Common shares reserved           110,000          
2020 Plan [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Warrants to purchase common shares           50,000          
Common shares reserved           3,110,000          
Number of shares outstanding           1,820,000          
Remaining shares           1,240,000          
2021 Stock Plan [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Warrants to purchase common shares           75,000          
Common shares reserved           8,740,000          
Number of shares outstanding           8,630,000          
Remaining shares           35,000          
Shares available for future grants           11,735,000          
NoveCite Stock Plan [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Common shares reserved           2,000,000          
Shares available for future grants           88,500          
Options vest over terms           10 years          
Stock-based compensation expense (in Dollars)           $ 130,382 $ 133,332        
Common shares outstanding           1,911,500          
Granted options to purchase               2,000,000      
Weighted average exercise price per share (in Dollars per share)               $ 0.24      
Options to purchase were forfeited           88,500          
options to purchase were exercisable           1,673,625          
Term of options outstanding           7 years 4 months 20 days          
Unrecognized total compensation cost (in Dollars)           $ 47,575          
Weighted average period           8 months 1 day          
Citius Oncology plan [Member]                      
Common Stock, Stock Options and Warrants [Line Items]                      
Share price per value (in Dollars per share)           $ 1.65          
Common shares reserved                     15,000,000
Options vest over terms           10 years          
Stock-based compensation expense (in Dollars)           $ 1,965,500          
Granted options to purchase           12,750,000          
Weighted average exercise price per share (in Dollars per share)           $ 2.15          
Options to purchase were forfeited           150,000          
options to purchase were exercisable           655,556          
Term of options outstanding           9 years 9 months 7 days          
Unrecognized total compensation cost (in Dollars)           $ 18,882,500          
Weighted average period           2 years 7 months 20 days